🔗 Share this article

As the United States continues making unprecedented adjustments to its immunization guidelines, one figure has emerged in a surprising turn: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who initially gained attention by expressing skepticism about Covid shots throughout the global health crisis and has focused upon possible deaths after Covid vaccination in her short time at the FDA.

Proposed Changes to Pediatric Vaccine Schedule

Agency leaders were set to announce major changes to the pediatric vaccine schedule earlier this month, aligning the US with Denmark’s national calendar, it is understood – a significant shift that would put the US out of step with many the international standard with no evidence for benefit. The announcement has been delayed until the coming year.

In place of the top vaccines chief, Dr. Høeg is set to speak at the event. She was recently named temporary leader of the FDA’s CDER, the fifth individual to head the center this year.

A New Direction at the Regulatory Body

Høeg's temporary position could signify a strengthened alliance between the drug and vaccine centers as Høeg and Dr. Prasad solidify control at the agency – and it points to a renewed priority upon rolling back long-standing immunizations at the FDA.

Høeg has often pushed for ending certain childhood shot schedules in the US in order to be more in line with Denmark, a country with universal health coverage and a population approximately the size of the state of Wisconsin.

So far comments, she has kept her attention on vaccines – traditionally the responsibility of Dr. Prasad, chief of the FDA’s vaccine center – rather than drug regulation.

Questions Over Background

Høeg has little discernible track record in medication creation, regulation or leadership, which has been typical for past heads of the CBER. She has worked at the FDA as a senior adviser to the FDA chief and CBER since earlier this year.

“She doesn’t seem to have the necessary background” for leading the CDER, remarked Dr. Jonathan Howard. “She lacks experience running a scientific study. She is not versed in managing a sizeable institution. She lacks background in drug approvals.”

Previous commissioners of CBER would “understand legal statutes and the underlying principles of drug development”, said Dr. Janet Woodcock. “Objectively, she lacks the sort of resume that former directors who ran CBER have had.”

CDER has an immense range of responsibilities at the agency, the former commissioner pointed out.

“The public just pays attention on the novel medication approvals, but the generic drug division authorizes a multitude of generic drugs. There’s a biologic copycat branch, OTC medication office and other areas, and each of these need to be managed,” Woodcock noted. “The area you don’t keep your eye on, that is the part that I always told people is going to bite you.”

Additionally, a substantial management element to the position, which oversees over 5,000 employees. “It’s a enormous administrative position, if you do it right,” Woodcock concluded.

Response and Contentious Programs

In response to questions about Høeg’s fitness for the role and whether this selection represents greater collaboration among regulatory chiefs on vaccines, a spokesperson said that the “inquiries stem from inaccurate premises”.

“This background matches the duties of her role,” the official said, pointing to the period Høeg spent advising the agency head on “pharmaceutical safety and regulatory science, including predictive safety algorithms and shot safety tracking”.

As the temporary head, Dr. Høeg inherits the commissioner’s new fast-track approval initiative, a disputed rapid therapy clearance system that reportedly concerned her predecessors. “By what process are these drugs being selected for this voucher program? Who makes the choices?” Howard questioned. “There’s a lot of confidentiality happening at the regulatory body right now.”

In general, he stated, “the Food and Drug Administration appears to be shifting towards less stringent regulations of most medications, aside from vaccines.”

Established Track Record on Immunizations

With immunizations, Høeg has a more documented, if concerning, past, Howard observe. She released a analysis using non-validated public submissions to estimate the frequency of myocarditis after COVID-19 vaccination. She advised the state of Florida surgeon general Joseph Ladapo, who reportedly have changed statistics to imply Covid vaccinations are pose a greater threat than they are.

Among her “desired changes” for the new administration encompassed revising guidelines for new vaccines and discontinuing “non-essential” vaccines, she remarked post-election on a podcast. At the agency, Høeg has allegedly suggested preventing adolescent males from obtaining COVID-19 vaccines.

“She is an all-around dogmatist who starts off with her beliefs and tailors the evidence to fit the science in a extremely deceptive, fraudulent way,” Dr. Howard stated.

Gaining Influence and a “Revenge Tour”

Høeg became part of other skeptics, {like|